News

Approaches such as machine learning, AI and neural networks are still in their infancy, but with AI companies rewriting the code for drug discovery, the implications in pharma are likely to be far ranging in the coming years.

Italy-based CRO Exom Group has announced the launch of its electronic informed consent solution, Genius Engage.

With the availability of workflow-based study start-up tools, proactive planning is within reach for stakeholders who view this function as pivotal to improving clinical trial quality.

Examining the potential of such diagnostic technologies in reshaping oncology trials.

Updated employee announcements, business news, awards and recognition in the industry today.

Functional service provisions can provide sponsors and CROs with a way to efficiently manage clinical trial outsourcing methods.

Ensuring the supply of clinical drugs during a time of crisis is a necessary moral and ethical action to take. This decision-making framework integrates real-world signals with supply planning techniques to reduce supply chain risk and avoid potential supply interruptions.

Cancer's R&D Convergence will highlight the changing landscape for clinical trials in this therapeutic area based on the promise of the Cancer MoonShot initiative, along with new oncology immunotherapies.

The Belgian health ministry has decreed that Belgian lung-cancer patients can receive and be reimbursed for immunotherapy treatments.

CISCRP has shared a recent supplement on clinical trials in USA Today magazine.

Clinical trial data from completed trials are now beginning to be shared through a variety of channels. While skeptics remain, evidence is growing that this data can lead to practice-changing behavior in patient care.

DrugDev and Citeline, part of Informa’s Pharma Intelligence vertical, announced that data from Citeline’s Trialstrove and Sitetrove platforms have been integrated.

INC Research and inVentiv Health announced that their Boards of Directors have unanimously approved a merger agreement.

iCardiac announced that it has been selected to work on an early phase oncology clinical trial with a global Japanese pharma company.

ERT announced the acquisition of ImageIQ, originally established as Cleveland Clinic’s Biomedical Imaging and Analysis Center.

Dr. George Atiee shares his perspectives, from that of the principal investigator, on how stakeholders can execute a successful study.

WIRB-Copernicus Group (WCG) has announced the acquisition of MedAvante and ProPhase, and has named Dr. Jeffrey Litwin as CEO of the combined organization.

The EU’s national health organizations are contemplating to abandon their highly-prized autonomy, and forge common positions and buying strategies for accessing expensive new drugs.

Transparency regarding the source of biospecimens would improve research quality, reproducibility, and translational use of acquired knowledge. Scientific robust publications, dissemination and communication are central to this-as are the regulatory reporting guidelines in play.

Medidata introduced the availability of its regulated content management platform (RCM), Medidata RCM.